Cargando…
Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR/CRISPR‐associated protein 9–Mediated Gene Editing
BACKGROUND AND AIMS: Patients with glycogen storage disease type 1a (GSD‐1a) primarily present with life‐threatening hypoglycemia and display severe liver disease characterized by hepatomegaly. Despite strict dietary management, long‐term complications still occur, such as liver tumor development. V...
Autores principales: | Rutten, Martijn G.S., Derks, Terry G.J., Huijkman, Nicolette C.A., Bos, Trijnie, Kloosterhuis, Niels J., van de Kolk, Kees C.W.A., Wolters, Justina C., Koster, Mirjam H., Bongiovanni, Laura, Thomas, Rachel E., de Bruin, Alain, van de Sluis, Bart, Oosterveer, Maaike H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597008/ https://www.ncbi.nlm.nih.gov/pubmed/34157136 http://dx.doi.org/10.1002/hep.32022 |
Ejemplares similares
-
Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
por: Rutten, Martijn G. S., et al.
Publicado: (2023) -
Next-generation glycogen storage diseases
por: Derks, Terry G. J., et al.
Publicado: (2018) -
Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
por: Hoogerland, Joanne A., et al.
Publicado: (2021) -
Increased atherosclerosis in a mouse model of glycogen storage disease type 1a
por: La Rose, Anouk M., et al.
Publicado: (2022) -
Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism
por: Blankestijn, Maaike, et al.
Publicado: (2022)